Robert D. Lister - Mar 7, 2024 Form 4 Insider Report for IMAX CORP (IMAX)

Signature
/s/ Kenneth I. Weissman (attorney-in-fact for Robert D. Lister)
Stock symbol
IMAX
Transactions as of
Mar 7, 2024
Transactions value $
-$558,298
Form type
4
Date filed
3/11/2024, 04:45 PM
Previous filing
Mar 13, 2023
Next filing
Mar 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMAX common shares Options Exercise $0 +14.7K +10.94% $0.00 149K Mar 7, 2024 Direct F1
transaction IMAX common shares Options Exercise $0 +12K +8.01% $0.00 161K Mar 7, 2024 Direct F1
transaction IMAX common shares Options Exercise $0 +13K +8.03% $0.00 174K Mar 7, 2024 Direct F1
transaction IMAX common shares Tax liability -$355K -21.1K -12.12% $16.80 153K Mar 7, 2024 Direct F2
transaction IMAX common shares Award $0 +22.9K +14.93% $0.00 176K Mar 7, 2024 Direct F3
transaction IMAX common shares Tax liability -$203K -12.1K -6.88% $16.80 164K Mar 7, 2024 Direct F4
holding IMAX common shares (opening balance) 135K Mar 7, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMAX restricted share units Options Exercise $0 -14.7K -100% $0.00* 0 Mar 7, 2024 common shares 14.7K $0.00 Direct F1, F5, F6, F7, F10
transaction IMAX restricted share units Options Exercise $0 -12K -50% $0.00 12K Mar 7, 2024 common shares 12K $0.00 Direct F1, F5, F6, F8, F10
transaction IMAX restricted share units Options Exercise $0 -13K -33.33% $0.00 25.9K Mar 7, 2024 common shares 13K $0.00 Direct F1, F5, F6, F9, F10
transaction IMAX restricted share units Award $0 +43K $0.00 43K Mar 7, 2024 common shares 43K $0.00 Direct F5, F6, F7, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted share units into common shares.
F2 Mr. Lister is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions.
F3 Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2021. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period.
F4 Mr. Lister is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance share unit transactions.
F5 Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
F6 Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
F7 The restricted share units vest and will be converted to common shares in three equal installments on each of the first three anniversaries of the grant date.
F8 The restricted share units vest and will be converted to common shares in three installments: 11,957 on each of March 7, 2023 and March 7, 2024 and 11,959 on March 7, 2025.
F9 The restricted share units vest and will be converted to common shares in three installments: 12,957 on each of March 7, 2024 and March 7, 2025 and 12,959 March 7, 2026.
F10 This represents the number of restricted share units for this transaction only. Mr. Lister's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 106,053, 80,850 and 163,889, respectively. The number of outstanding options reflects the expiration of options to purchase 39,909 common shares on March 7, 2024. Mr. Lister did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d).